The company also reported GAAP net income of $8.5 million for the second quarter of 2012, compared to GAAP net income of $0.7 million for the second quarter of 2011. However, the company's United States spine business reported a 4 percent decrease over the same period last year, reaching only $45.7 million in the second quarter.

In the United States, the orthopedics business grew 22 percent to $80.7 million but dropped 2 percent internationally. The company's U.S. neurosurgery market grew only 2 percent while the international market saw a 5 percent decrease. Worldwide, the neurosurgery market decreased by 1 percent to $67.7 million.

"We had a good quarter across all our businesses and are making solid progress against our priorities," said Peter Arduini, Integra LifeSciences president and CEO. "Revenues, gross margin and earnings per share all increased both year-over-year and sequentially."

More Articles on Orthopedic Devices:

Minimally Invasive Surgery Market to Reach $35.5B by 2016

MiMedx Revenues Reach $4.9M in 2Q, 153% Increase

China Device Market Expected Grew at 20.5% CAGR From 2006-2011